Clinical-stage biotech founded in 1995 and based in Cleveland, Ohio, developing MultiStem®, an allogeneic stem-cell therapy platform. Focused on conditions such as neurological injury, acute respiratory distress syndrome, and immune-mediated inflammation. MultiStem is designed as a scalable, off-the-shelf therapy with immunomodulatory and tissue-repair functions. (athersys.com)...